Top

The European Journal of Health Economics

Published in:

01-01-2010 | Original Paper

The disease burden of colorectal cancer in Hungary

Authors: Imre Boncz, Valentin Brodszky, Márta Péntek, István Ágoston, Zsolt Nagy, Krisztián Kárpáti, Ildikó Kriszbacher, Péter Fuszek, László Gulácsi

Published in: The European Journal of Health Economics | Special Issue 1/2010

Abstract

The aim of the paper is to give an overview of the epidemiology, treatment pattern and quality, as well as policy issues and disease burden of colorectal cancer (CRC) in Hungary. Colorectal cancer is the second most common cause of cancer-related death in both males and females in Hungary. The Hungarian Cancer Registry collects data on the epidemiological characteristics of CRC. Two pilot programmes (1997/1998 and 2003/2004) were conducted for population-based screening of CRC using both immunological and guaiac faecal occult blood testing (FOBT). The National Health Insurance Fund Administration (NHIFA) spends altogether € 38.9 million a year on the treatment of CRC. It is hoped that the introduction of an accepted and cost-effective screening programme for CRC can reduce the high CRC burden in Hungary.

Boncz, I., Nagy, J., Sebestyen, A., Korosi, L.: Financing of health care services in Hungary. Eur. J. Health Econ. 5, 252–258 (2004)CrossRef

Gulácsi, L., David, T., Dózsa, C.S.: Pricing and reimbursement of drugs and medical devices in Hungary. Eur. J. Health Econ. 3, 271–278 (2002)CrossRef

Boncz, I., Sebestyen, A.: Financial deficits in the health services of the UK and Hungary. Lancet 368, 917–918 (2006)CrossRef

Dobrossy, L.: Cancer mortality in central-eastern Europe: facts behind the fi gures. Lancet Oncol. 3, 374–381 (2002)CrossRef

Boncz, I., Sebestyen, A., David, T.: Comparative analysis of drug cost of breast, cervical and colorectal cancer in Hungary. Value Health 8, A42 (2005)

Ottó, S., Kásler, M.: Trends in cancer mortality and morbidity in Hungarian and international statistics. Characteristics and potential outcome of public health screening programs. Magy. Onkol. 49, 99–101 and 103–107 (2005)

Hungarian National Cancer Registry (2001)

Tusnády, G., Gaudi, I., Rejto, L., Kásler, M., Szentirmay, Z.: Survival chances of Hungarian cancer patients in the national cancer registry. Magy. Onkol. 52, 339–349 (2008)CrossRef

Jensen, O.M., Parkin, D.M., MacLennan, R., Muir, C.S., Skeet, R.G.: Cancer Registration: Principles and Methods. IARC Scientific Publications No. 95, Lyon, France (1991)

10.

Kovács, L., Pataki, M.: New Hungarian National Cancer Registry. ERCIM NEWS. January, 58 (2007)

11.

Tusnády, G., Gaudi, I., Rejto, L., Kásler, M., Szentirmay, Z.: Survival chances of Hungarian cancer patients in the national cancer registry (Translated from Hungarian: a magyar daganatos betegek túlélési esélye a Nemzeti Rákregiszter adatai alapján). Magy. Onkol. 52, 339–349 (2008)CrossRef

12.

Ottó, S.Z., Kasler, M.: Cancer mortality and incidence in Hungary in relation to international data. Magy. Onkol. 46, 111–117 (2002)

13.

Ministry of Health: Hungarian National Cancer Control Programme. Budapest (2006)

14.

Ottó, S., Németh, M.: Double immunochemical screening test (hemoglobin and albumin) for the detection of occult intestinal bleeding. J. Clin. Lab. Anal. 7, 301–306 (1993)CrossRef

15.

Boncz, I., Sebestyén, A., Dózsa, C., et al.: Health economics analysis of colorectal screening. (Translated from Hungarian: a colorectalis szűrések egészség-gazdaságtani elemzése). Magy. Onkol. 48, 111–115 (2004)

16.

Csonka, C., Molnár, C., Németh, M., Ottó, S.: Results of and experinces with colorectal screening in town Ajka (Translated from Hungarian: Az ajkai vastagbélszűrés eredményei és tapasztalatai). Magy. Onkol. 48, 29 (2004)

17.

Boncz, I., Sebestyen, A., Pinter, I., Betlehem, J., Kriszbacher, I., Csere, T., Mangel, L., Bodis, J.: Age-group specific gap between treatment cost of and mortality due to breast and colorectal cancer. J. Clin. Oncol. 25, 4501–4502 (2007)CrossRef

18.

Ottó, S., Döbrőssy, L.: Screening for colorectal cancer with immunological FOBT. Br. J. Cancer 90, 1871–1872 (2004)

19.

Döbrősy, L., Kovács, A., Budai, A., Cornides, A., Ottó, S., Tulassay, Z.: The state of the colorectal screening in Hungary: lessons of the pilot programs. Orv. Hetil. 148, 1787–1793 (2007)CrossRef

20.

Boncz, I., Sebestyen, A., Dobrossy, L., Pentek, Z., Budai, A., Kovacs, A., Dozsa, C., Ember, I.: The organization and results of first screening round of the Hungarian nationwide organised breast cancer screening programme. Ann. Oncol. 18, 795–799 (2007)CrossRef

21.

Boncz, I.: Organized nationwide breast cancer screening programme was introduced in Hungary in 2002. Swiss. Med. Wkly. 136, 328 (2006)

22.

Boncz, I., Sebestyen, A., Pinter, I., Battyany, I., Ember, I.: The effect of an organized, nationwide breast cancer screening programme on non-organized mammography activities. J. Med. Screen 15, 14–17 (2008)CrossRef

23.

Boncz, I.: Prevention of cervical cancer screening in low-resource settings. JAMA 295, 1248 (2006)CrossRef

24.

Kovács, A., Döbrőssy, L., Budai, A., Boncz, I., Cornides, Á.: Cervical screening in Hungary: why does the “English model” work but the “Hungarian model” does not? Eur. J. Gynaecol. Oncol. 29, 5–9 (2008)

25.

Boncz, I., Sebestyen, A., Ember, I.: Organized, nationwide cervical cancer screening programme in Hungary. Gynecol. Oncol. 106, 272–273 (2007)CrossRef

26.

Barry, M.J.: Screening for prostate cancer—the controversy that refuses to die. N. Engl. J. Med. 360, 1351–1354 (2009)CrossRef

27.

Schröder, F.H., Hugosson, J., Roobol, M.J., ERSPC Investigators, et al.: Screening and prostate-cancer mortality in a randomized European study. N. Engl. J. Med. 360, 1320–1328 (2009)CrossRef

28.

Andriole, G.L., Grubb 3rd, R.L., Buys SS, P.L.C.O., Team, Project., et al.: Mortality results from a randomized prostate-cancer screening trial. N. Engl. J. Med. 360, 1310–1319 (2009)CrossRef

29.

Boncz, I., Sebestyen, A., Betlehem, J., et al.: The effect of the performance volume limit (PVL) on the DRG financing of the Hungarian hospitals. Value Health 11, A48 (2008)

30.

Decree of the Ministry of Health, Social and Family Affairs on the principles of inclusion of registered medicinal and special nutritional products into the reimbursement system and on the modification of the inclusion or reimbursement status. 32/2004. (IV.26.) (2004)

31.

Act XCVIII of 2006 on safety and efficient supply of pharmaceuticals and medical devices as well as on the general rules of pharmaceuticals distribution. Official Gazette No. 146; 29 November 2006

32.

Act XCVIII of 2006 on safety and efficient supply of pharmaceuticals and medical devices as well as on the general rules of pharmaceuticals distribution. Official Journal No. 146; 29 November 2006

33.

Wilking, N., Jönsson, B.: A Pan-European Comparison Regarding Patient Access to Cancer Drugs. Karolinska Institutet in collaboration with Stockholm School of Economics Stockholm, Sweden (2005)

34.

Hungarian College of Surgeons on behalf of the Ministry of Health: Professional protocoll of colorectal and anal cancer. (Translated from Hungarian: Az Egészségügyi Minisztérium szakmai protokollja Vastagbél- és végbélrák Készítette: A Sebészeti Szakmai kollégium). Budapest (2006)

35.

Harisi, R., Bodoky, G., Borsodi, M., Flautner, L., Weltner, J.: Rectal cancer therapy: decision making on basis of quality of life? Zentralbl. Chir. 129, 139–148 (2004)CrossRef

36.

Hungarian Ministry of Health. List of professional guidelines. http://www.eum.hu/egeszsegpolitika/minosegfejlesztes/szakmairanyelvek. Accessed August 2009

Title: The disease burden of colorectal cancer in Hungary
Authors: Imre Boncz
Valentin Brodszky
Márta Péntek
István Ágoston
Zsolt Nagy
Krisztián Kárpáti
Ildikó Kriszbacher
Péter Fuszek
László Gulácsi
Publication date: 01-01-2010
Publisher: Springer-Verlag
Published in: The European Journal of Health Economics / Issue Special Issue 1/2010
Print ISSN: 1618-7598
Electronic ISSN: 1618-7601
DOI: https://doi.org/10.1007/s10198-009-0192-z

Keynote webinar | Spotlight on medication adherence

Springer Medicine

The disease burden of colorectal cancer in Hungary

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Special Issue 1/2010

Colorectal cancer in Russia

Colorectal cancer in Portugal

Colorectal cancer in Turkey: current situation and challenges for the future

Colorectal cancer in Mexico: should a middle income country invest in screening or in treatment?

Colorectal cancer management in the United Kingdom: current practice and challenges

Colorectal cancer care in Denmark: status and dilemmas